TIFA anticorps (AA 51-150) (AbBy Fluor® 750)
-
- Antigène Voir toutes TIFA Anticorps
- TIFA (TRAF-Interacting Protein with Forkhead-Associated Domain (TIFA))
-
Épitope
- AA 51-150
-
Reactivité
- Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp TIFA est conjugé à/à la AbBy Fluor® 750
-
Application
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Réactivité croisée
- Souris
- Homologie
- Human,Rat,Dog,Cow,Sheep,Pig,Chicken
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human TIFA
- Isotype
- IgG
- Top Product
- Discover our top product TIFA Anticorps primaire
-
-
- Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- TIFA (TRAF-Interacting Protein with Forkhead-Associated Domain (TIFA))
- Autre désignation
- TIFA (TIFA Produits)
- Synonymes
- anticorps TIFA, anticorps xtifa, anticorps T2BP, anticorps T6BP, anticorps TIFAA, anticorps T2bp, anticorps Ab2-389, anticorps TRAF interacting protein with forkhead associated domain, anticorps TRAF-interacting protein with forkhead-associated domain, anticorps TRAF-interacting protein with forkhead-associated domain S homeolog, anticorps TIFA, anticorps tifa, anticorps Tifa, anticorps tifa.S
- Sujet
-
Synonyms: Putative MAPK activating protein PM14, Putative MAPK-activating protein PM14, Putative NF kappa B activating protein 20, Putative NF-kappa-B-activating protein 20, T2BP, TA, TA_HUMAN, TRAF interacting protein with FHA domain containing protein A, TRAF-interacting protein with FHA domain-containing protein A, TRAF2 binding protein, TRAF2-binding protein.
Background: Adapter protein which mediates the IRAK1 and TRAF6 interaction following IL-1 stimulation, resulting in the downstream activation of NF-kappa-B and AP-1 pathways. Induces the oligomerization and polyubiquitination of TRAF6, which leads to the activation of TAK1 and IKK through a proteasome-independent mechanism.
-